<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(AMENDMENT NO. 2) *
ENDOSONICS CORPORATION
- --------------------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK, $.001 PAR VALUE PER SHARE
- --------------------------------------------------------------------------------
(Title of Class of Securities)
29264k105
-------------------------------------------------------
(CUSIP Number)
GILBERT H. DAVIS, ESQ.
SIMS MOSS KLINE & DAVIS LLP
400 NORTHPARK TOWN CENTER, SUITE 310
1000 ABERNATHY ROAD, N.E.
ATLANTA, GEORGIA 30328
(770) 481-7210
-------------------------------------------------------
(Name, Address and Telephone Number of Persons
Authorized to Receive Notices and
Communications)
SEPTEMBER 29, 1998
-------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ].
Note: Six copies of this statement, including all exhibits, should be filed with
the Commission. See Rule 13d-1(a) for other parties to whom copies are sent.
1
<PAGE>
13D
CUSIP No. 29264k105
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON:
James O. Patterson
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [X]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS: WC, OO
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) or 2(e) [ ]
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION: United States
- --------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER: 1,015,000
SHARES ----------------------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER: NONE
OWNED BY ----------------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER: 1,015,000
REPORTING ----------------------------------------------------------------
PERSON 10 SHARED DISPOSITIVE POWER: NONE
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON: 1,015,000
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [ ]
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11): 6.47%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON: IN
- --------------------------------------------------------------------------------
2
<PAGE>
Pursuant to Rule 13d-2(a) of Regulation 13D-G of the General Rules and
Regulations under the Securities Exchange Act of 1934, as amended (the "Act"),
the undersigned hereby amend their Schedule 13D Statement dated June 19, 1998,
as previously amended pursuant to Amendment No.1 thereto dated July 22, 1998,
relating to the common stock, $.001 par value, of Endosonics Corporation
("Company") (such initial Schedule 13D and the prior amendments thereto shall
hereinafter be referred to as the "Statement"). Unless otherwise indicated, all
defined terms used in this Amendment No. 2 to the Statement (this "Amendment")
shall have the same meanings as those set forth in the Statement. There has
been no material change in the information included in the Statement except as
regards the information contained in Item 5 of the Statement, which is
supplemented as set forth below.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.
------------------------------------
As of October 1, 1998, Phoenix, Falcon Fund and Mustang had purchased shares
of Company stock such that Mr. Patterson's beneficial ownership had been
increased to 1,015,000 shares, or approximately 6.47% of outstanding shares. Of
those shares, 369,521 (2.35% of outstanding shares) were owned directly by
Phoenix, 295,479 (1.88% of outstanding shares) were owned directly by Falcon
Fund and 350,000 (2.23% of outstanding shares) were owned directly by Mustang.
The percentages of outstanding shares of the Company stock set out in the
preceding paragraph are computed based on a total of 15,692,080 outstanding
shares of Company stock as of June 30, 1998, as indicated by the Company's
Quarterly Report on Form 10-Q for the quarter ended June 30, 1998.
During the 60 days prior to October 1, 1998, the parties filing the
Statement have engaged in the following transactions in shares of the Company
stock:
NO. OF SHARES PRICE
DATE PARTY PURCHASED/(SOLD) PER SHARE
- -------- ----------- ---------------- ---------
09/02/98 Phoenix 30,833 $6.22
09/29/98 Phoenix 59,976 $4.92
09/30/98 Phoenix 2,117 $4.88
09/02/98 Falcon Fund 19,167 $6.22
09/29/98 Falcon Fund 40,024 $4.92
09/30/98 Falcon Fund 50,383 $4.88
09/29/98 Mustang 100,000 $4.92
09/30/98 Mustang 50,000 $4.88
Each of the above transactions was effected on the open market through the
National Association of Securities Dealers, Inc. Automated Quotation Systems
(NASDAQ).
3
<PAGE>
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: October 1, 1998 /s/ James O. Patterson
--------------------------------
James O. Patterson
PHOENIX
Date: October 1, 1998 By: /s/ James O. Patterson
-----------------------------
James O. Patterson, Managing
General Partner
FALCON FUND INTERNATIONAL
PARTNERSHIP
By: Falcon Fund, Investment
General Partner
By: J.O. Patterson & Co., General
Partner
Date: October 1, 1998 By: /s/ James O. Patterson
------------------------------
James O. Patterson, President
4
